Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Clinical Nuclear Medicine|April 26, 2020
18F-PSMA 1007 Uptake in a Man With Metastatic Breast CancerFahad Marafi, Arun Sasikumar, Mahamoud Alfeeli, et al.
Clinical Nuclear Medicine|August 15, 2021
18F-PSMA-1007 Uptake in Paget Disease of the Bone: An "Iron Man" SignMahamoud Alfeeli, Fahad Marafi, Abdulredha Esmail, et al.
Clinical Nuclear Medicine|June 5, 2019
18F-PSMA 1007 Brain PET/CT Imaging in Glioma RecurrenceFahad Marafi, Arun Sasikumar, Wael Fathallah, et al.
Clinical Nuclear Medicine|November 7, 2019
18F-PSMA 1007 Uptake in Brain Metastases From Breast CancerFahad Marafi, Arun Sasikumar, Mahmoud Alfeeli, et al.
Clinical Nuclear Medicine|November 12, 2020
18F-PSMA-1007 PET/CT for Initial Staging of Renal Cell Carcinoma in an End-Stage Renal Disease PatientFahad Marafi, Arun Sasikumar, Mariam Aldaas, et al.
Clinical Nuclear Medicine|March 27, 2020
18F-PSMA 1007 in Suspected Renal Cell CarcinomaFahad Marafi, Arun Sasikumar, Abdullatif Al-Terki, et al.
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|March 1, 2017
Specificity of 68Ga-PSMA PET/CT for Prostate Cancer - Myths and RealityArun Sasikumar
Clinical Nuclear Medicine|April 16, 2019
68Ga-Prostate-Specific Membrane Antigen PET/CT in Cholangiocarcinoma: A Potential Biomarker for Targeted Radioligand Therapy?Fahad Marafi, Sharjeel Usmani, Abdulredha Esmail
The British Journal of Radiology|January 3, 2018
Initial experience with 18F-sodium fluoride (NaF) PET-CT: a viable functional biomarker in symptomatic Os acromialeSharjeel Usmani, Fahad Marafi, Abdulredha Esmail, et al.
Pageof 8